Post by
prone on Feb 19, 2021 7:22am
Members at work for MJ access ....
RE: Introduction to Cannabis Regulators Association
Dear Madam Speaker, Mr. Leader, Mr. Majority Leader, and Mr. Minority Leader:
The Cannabis Regulators Association (CANNRA) is a national organization that facilitates exchanges between policy makers and cannabis regulators from across the country.
CANNRA provides officials with unbiased information and recommendations regarding the impact and implementation of cannabis policies.
Our members are the primary regulatory agencies and officials charged with oversight of adult-use cannabis (also referred to as “recreational cannabis”) and/or medical cannabis
-->in the states of Arizona, California, Colorado, Connecticut, Delaware, Florida, Georgia, Hawaii, Illinois, Iowa, Louisiana, Maine, Massachusetts, Maryland, Michigan, Minnesota, Montana, Nevada, New Jersey, New York, North Dakota, Oregon, Rhode Island, South Dakota, Utah, Washington, and Washington D.C.
CANNRA is not a cannabis advocacy group and takes no formal position for or against cannabis legalization.
--> Our mission is to provide policy makers and regulatory agencies with the resources to make informed decisions when considering approaches to cannabis regulation.
The purpose of this letter is to introduce our association as a resource, so that interested members of Congress may benefit from the regulatory and implementation experiences of our members and the states they represent, and to provide a regulatory perspective on federal cannabis legislation.
States across the country continue to experiment with new and changing cannabis policy.
Each of the
---> thirtysix states and four territories that have
--->legalized some form of cannabis,
whether they permit the use of cannabis by patients to treat qualifying medical conditions, use by adults age twenty-one and older, or both,
--> has its own unique regulatory framework.
Licensed activities, tax mechanisms and rates, market structure, the role of local governments, marketing and advertising, approved qualifying medical conditions, and many more regulatory issues vary greatly between jurisdictions.